Buhisan, May Ann .
HRN: 04-00-04 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/26/2024
CEFUROXIME 500MG (TAB)
06/26/2024
07/03/2024
PO
500mg Tab
BID
Prom X 7 Hrs; S/P NSVD With RMLE
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes